Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease.
about
Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosisA method for improving SELDI-TOF mass spectrometry data quality.The potential of ecotoxicoproteomics in environmental monitoring: biomarker profiling in mussel plasma using ProteinChip array technology.Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid.A potential biomarker in the cord blood of preterm infants who develop retinopathy of prematurity.Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations.Genomic and post-genomic analyses of human prion diseasesUrinary alpha1-antichymotrypsin: a biomarker of prion infectionPrion disease diagnosis by proteomic profiling.Proteomics Discovery of Disease Biomarkers.Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.Application of "omics" to prion biomarker discovery.Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathyIdentification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.Ovine serum biomarkers of early and late phase scrapie.Searching for reliable premortem protein biomarkers for prion diseases: progress and challenges to date.A quantitative proteomic approach to prion disease biomarker research: delving into the glycoproteome.Biomarker discovery by novel sensors based on nanoproteomics approaches.Comparative peptidome analyses of the profiles of the peptides ranging from 1-10 KD in CSF samples pooled from probable sporadic CJD and non-CJD patients.Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome.CSF proteome: a protein repository for potential biomarker identification.Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects.Clinical proteomics in neurodegenerative disorders.Retroviral proteomics and interactomes: intricate balances of cell survival and viral replication.Proteomics of human neurodegenerative diseasesProteomic profiling of cerebrospinal fluid in Creutzfeldt-Jakob disease.Application of "Omics" Technologies for Diagnosis and Pathogenesis of Neurological Infections.Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.Constrained selected reaction monitoring: quantification of selected post-translational modifications and protein isoforms.Rational design of a low-affinity peptide for the detection of cystatin C in a fast homogeneous immunoassay.
P2860
Q24678722-54DF1B7E-8A05-4A4F-AE43-885A198C2B15Q31125985-94520D0F-AF70-48B1-BBEC-C641D79EA08BQ33227321-546DCF28-141A-4B14-A08A-FDD2B9A24AE7Q33241392-8769505F-C90C-44B5-9BB4-2403A9A4A644Q33269762-DCB4621C-B08F-4806-8522-B46E5B789988Q33282300-A03A1C9E-7BAB-45B2-8B98-246A60A99564Q33347355-4B014CE4-8051-4B48-9C4F-7BC434CFA901Q33389817-9F38AECA-9C20-461E-B8E4-29462A2BE44AQ33398738-62FCEA3E-69DD-4208-8CF8-768D625F7124Q33478412-D7011602-B4BF-47C8-A8E2-2D4F32154EC2Q33481896-89B4A597-E860-4403-AA6B-FA82BBFA390FQ33708360-AB06AEC6-E8AB-4935-863C-23F4D1A39744Q33769602-1423CDC2-263A-418F-97BF-B13244DF4E60Q33856292-D282070E-F2D9-44D8-8CA4-AC26709C1114Q34332056-065F8537-3C3C-4C91-BF65-8F9C51703A75Q34342895-7729C3D2-7F49-47C6-9CCF-DABABCA7CC6EQ35023878-48C8C639-0629-4FC4-A200-38B9605B87A3Q35831485-7C5ADA37-C8FA-408F-B9A4-FB8745EB7495Q35918933-A3B99AB9-5CB6-4F86-9F78-B4E1460096C3Q36012137-C8D2DD44-2C15-41F4-B60F-EF009F774C18Q36168470-85DB68F1-BB4A-4DC8-AE74-2E94F3DF41D6Q36615226-0827C747-C0F9-4CC5-855D-A6240821B603Q36722418-F107853B-61B5-49AF-B0B2-E695B3F975B2Q37086170-046E19B5-548C-4462-9C3B-6F4571A51B4CQ37183096-36A2BB51-6AB2-4A0E-AD8C-7BB8140D0AD4Q37260477-064BEDA0-0027-4E77-919E-DA69EBE5242CQ37818319-A64CAA83-5AD6-47CE-B5C9-155018A07CD2Q38551782-BA16AFCC-B809-45BE-AE97-65E7EFC566A2Q38643847-7C06011D-3BA1-4C53-80A8-E02E19739E05Q38806844-8B5E470B-39C7-44ED-A680-DDB1996CF0A8Q50931817-301802A5-B50E-4AA6-AD3C-9AF67A8F7651
P2860
Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cystatin C as a potential cere ...... of Creutzfeldt-Jakob disease.
@ast
Cystatin C as a potential cere ...... of Creutzfeldt-Jakob disease.
@en
type
label
Cystatin C as a potential cere ...... of Creutzfeldt-Jakob disease.
@ast
Cystatin C as a potential cere ...... of Creutzfeldt-Jakob disease.
@en
prefLabel
Cystatin C as a potential cere ...... of Creutzfeldt-Jakob disease.
@ast
Cystatin C as a potential cere ...... of Creutzfeldt-Jakob disease.
@en
P2093
P356
P1433
P1476
Cystatin C as a potential cere ...... s of Creutzfeldt-Jakob disease
@en
P2093
Alex Scherl
Denis F Hochstrasser
Elisabeth Guillaume
Jean-Charles Sanchez
Jennifer Burgess
Laure Allard
Odile Carrette
Pierre R Burkhard
P304
P356
10.1002/PMIC.200300799
P577
2004-08-01T00:00:00Z